Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Rare Neurological Disease Treatment Industry By 2029?
There has been significant growth in the market size of rare neurological disease treatments in the past years. There is projected to be an increase from $9.85 billion in 2024 to $10.64 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.0%. Factors contributing growth during the historical period encompass the prevalence of biosimilars in rare disease treatment, the global expansion of clinical trials, reforms in healthcare reimbursement policies, the designation of orphan drugs, and the advancement of genetic research.
The market size for the treatment of uncommon neurological conditions is anticipated to experience robust growth in the upcoming years. It is projected to expand to $14.75 billion by 2029, with a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this growth during the forecast period include advancements in diagnostic tools and precision medicine, a focus on patient-centered drug development, the adoption of real-world evidence, the use of telemedicine for patient support, and a shift towards personalized therapies. Key trends during this period will be technological innovations, the use of artificial intelligence in drug discovery, blockchain utilization for data protection, and the application of machine learning in drug discovery.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12146&type=smp
Which Factors Are Steering Growth In The Rare Neurological Disease Treatment Market?
The rise in instances of unique neurological conditions is forecasted to spur the expansion of the market for their treatment. These rare neurological disorders include but are not limited to, Huntington’s disease, ALS (amyotrophic lateral sclerosis), Rett syndrome, and multiple forms of muscular dystrophy. The management and treatment of these diseases involves comprehensive strategies to handle symptoms, slow the advancement of the disease, and improve life quality for those affected. For example, BioMed Central Ltd., a UK publisher of open-access scientific journals, reported in January 2023 that the collective occurrence of Rett syndrome was 7.1 per 100,000 females in a group of 9.57 million women, confirming a total of 673 cases. Thus, the growing instances of unique neurological diseases stimulate the expansion of their treatment market.
Which Segment Accounts For The Largest Share In The Rare Neurological Disease Treatment Market?
The rare neurological disease treatmentmarket covered in this report is segmented –
1) By Drug Type: Biologics; Small Molecules
2) By Therapy: Cognitive Behavioral Therapy; Interpersonal Psychotherapy; Cyberknife; Other Therapies
3) By Mode Of Administration: Oral; Injectable; Other Modes Of Administration
4) By Disorders: Aicardi Syndrome; Aicardi-Goutières Syndrome; Reflex Sympathetic Dystrophy Syndrome; Battaglia-Neri Syndrome; Creutzfeldt Jakob Disease; Agnosia; Other Disorders
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies And Drug Store; Online Pharmacies
Subsegments:
1) By Biologics: Monoclonal Antibodies; Gene Therapies; Recombinant Proteins
2) By Small Molecules: Targeted Small Molecules; Neuroprotective Agents; Anti-inflammatory Small Molecules
Which Long-Term Trends Will Play A Crucial Role In The Rare Neurological Disease Treatment Market?
The exploration and production of orphan drugs is an emerging trend in the therapeutic market for rare neurological conditions. Major market players within the domain of rare neurological disease treatment are concentrating their efforts on devising unique and specialized therapies to consolidate their market presence. Take, for example, Orphalan SA, a French-based orphan drug manufacturer, which rolled out Cuvrior, an innovative trientine tetrahydrochloride (TETA-4HCl) in the European market in April 2023. Cuvrior has been commercially launched to treat adult patients with stable Wilson disease who have undergone copper reduction therapy and exhibited tolerance to D-penicillamine. In April 2022, the drug was endorsed by the United States Food and Drug Administration (FDA) and awarded the orphan drug exclusivity (ODE) for this particular group of patients.
Who Are The Dominant Players In The Rare Neurological Disease Treatment Market Today?
Major companies operating in the rare neurological disease treatment market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Bayer AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi-Aventis SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Medtronic PLC, Teva Pharmaceutical Industries Ltd., CSL Limited, Biogen Inc., UCB S.A., Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Jazz Pharmaceuticals PLC, Mitsubishi Tanabe Pharma Corporation, Neurocrine Biosciences Inc., Kedrion Biopharma Inc., Merz Pharma GmbH & Co. KGaA, Harmony Biosciences Holdings Inc., Amicus Therapeutics Inc., Revance Therapeutics Inc., Aquestive Therapeutics Inc., US WorldMeds LLC (Solstice Neurosciences LLC), Stoke Therapeutics Inc., Retrotope Inc.
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Rare Neurological Disease Treatment Market?
North America was the largest region in the rare neurological diseases treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare neurological disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12146&type=smp
Browse Through More Reports Similar to the Global Rare Neurological Disease Treatment Market 2025, By The Business Research Company
Motor Vehicle And Parts Dealers Global Market Report 2025
Automobiles And Heavy Equipment Global Market Report 2025
Electric Motor And Generator Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model